436 results on '"Turner, Alice M"'
Search Results
2. Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project
3. Baseline characteristics from a 3-year longitudinal study to phenotype subjects with COPD: the FOOTPRINTS study
4. The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO
5. The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial
6. Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
7. Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ)
8. Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry
9. Less Social Deprivation Is Associated With Better Health-Related Quality of Life in Asthma and Is Mediated by Less Anxiety and Better Sleep Quality
10. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
11. Prevalence of Cardiovascular Disease and Rate of Major Adverse Cardiovascular Events in Severe Alpha-1 Antitrypsin Deficiency COPD
12. Global mortality and readmission rates following COPD exacerbation-related hospitalisation : a meta-analysis of 65 945 individual patients
13. Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients
14. Exploring the causes of COPD misdiagnosis in primary care: A mixed methods study
15. Global mortality and readmission rates following COPD exacerbation-related hospitalization: a meta-analysis of 65945 individual patients
16. Prevalence of Cardiovascular Disease and Rate of Major Adverse Cardiovascular Events in Severe Alpha-1 Antitrypsin Deficiency COPD
17. Review article: New developments in biomarkers and clinical drug development in alpha‐1 antitrypsin deficiency‐related liver disease.
18. Sex differences between women and men with COPD: A new analysis of the 3CIA study
19. Are clinical trials into emerging drugs for the treatment of alpha-1 antitrypsin deficiency providing promising results?
20. COVID-19 infodemic and health-related quality of life in patients with chronic respiratory diseases: A multicentre, observational study
21. Colour vision deficiency and sputum colour charts in COPD patients: an exploratory mixed-method study
22. Predicting Postoperative Lung Function Following Lung Cancer Resection: A Systematic Review and Meta-analysis
23. Late presentation of acute hypercapnic respiratory failure carries a high mortality risk in COPD patients treated with ward-based NIV
24. Interventions for the management and prevention of sarcopenia in the critically ill: A systematic review
25. Experience-based co-design to improve a pulmonary rehabilitation programme
26. Does Continuous Positive Airway Pressure (CPAP) treatment of obstructive sleep apnoea (OSA) improve asthma-related clinical outcomes in patients with co-existing conditions?- A systematic review
27. Cluster randomised controlled trial of specialist-led integrated COPD care (INTEGR COPD).
28. Can guidelines rein in oxygen use? A retrospective cross-sectional study using routinely collected data
29. Mortality and readmission after COPD exacerbation-related hospitalization: an individual patient data meta-analysis
30. What are the radiological, microbiological and biochemical characteristics of bronchiectasis in alpha-1 antitrypsin deficiency? A systematic review
31. Alpha-1 antitrypsin (AAT) augmentation and the liver phenotype of adults with AAT deficiency (genotype Pi*ZZ)
32. Predicting Lung Function Using Biomarkers in Alpha-1 Antitrypsin Deficiency
33. Using multi-criteria decision analysis to describe stakeholder preferences for new quality improvement initiatives that could optimise prescribing in England
34. Less social deprivation is associated with better health-related quality of life (HRQoL) in asthma and is mediated by less anxiety and better sleep quality
35. Estimating the Prevalence of AATD Patients in the UK to Identify Underdiagnosis and Determine the Eligibility for Potential Augmentation Therapy
36. Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry
37. The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO
38. Airborne occupational exposures associated with pulmonary sarcoidosis: a systematic review and meta-analysis.
39. Treatment of lung disease in patients with AATD
40. Using multi-criteria decision analysis to describe stakeholder preferences for new quality improvement initiatives that could optimise prescribing in England
41. Phase III, two arm, multi-centre, open label, parallel-group randomised designed clinical investigation of the use of a personalised early warning decision support system to predict and prevent acute exacerbations of chronic obstructive pulmonary disease: ‘Predict & Prevent AECOPD’ – study protocol
42. Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease Patients with Underlying Alpha-1 Antitrypsin Deficiency: A Systematic Review and Practical Recommendations
43. Quality of Life and Mortality Outcomes for Augmentation Naïve and Augmented Patients with Severe Alpha-1 Antitrypsin Deficiency
44. Targeted case finding for chronic obstructive pulmonary disease versus routine practice in primary care (TargetCOPD): a cluster-randomised controlled trial
45. Additional file 3 of The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial
46. Additional file 1 of The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial
47. Additional file 2 of The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial
48. Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration
49. Using multi-criteria decision analysis to describe stakeholder preferences for new quality improvement initiatives that could optimise prescribing in England: A case study
50. Feasibility of a pulmonary rehabilitation programme for patients with symptomatic chronic obstructive pulmonary disease in Georgia: a single-site, randomised controlled trial from the Breathe Well Group
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.